Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics?
about
Tacrolimus and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: An interaction study in CYP3A5 non-expressors, renal transplant recipients.Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse ModelPatient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation.Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients.Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.Pharmacogenetics of immunosuppressants: progress, pitfalls and promises.CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation.A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.Update on the clinical pharmacogenomics of organ transplantation.Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients.Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.The personalized medicine revolution: getting it right for children.
P2860
Q35157102-D693286B-025E-4C54-9F4E-2C683942BE43Q35954058-E14EE3AB-C645-4180-838B-129139338005Q36327259-7A255F92-7F71-457D-B0DE-DA9CD539603BQ36814786-DF6CA756-A9C2-46BE-82C8-4CDE0BDDF05CQ37157896-815AAFDC-7DF7-4B39-B174-00EDCDD59558Q37176567-9FE6B44E-33DD-4FD5-9429-668416A2A733Q37478703-417772AD-FBAF-4CB6-8BDC-6B6085B09614Q38691788-BB931756-C0D0-4A45-B906-B7069BB997B3Q39903042-8162B561-F3D8-48E1-9AFA-BF7E66F80D3CQ42837771-A3F878EC-08A4-4A13-AB06-D6207EE270F8Q42840160-74F93F43-211F-4797-86A5-B6B1A9C69DE5Q43296441-1A30BAF9-3200-426D-8D43-C1DFAFE9CCC5Q46173047-1F42E9DD-A09F-4B31-811F-1B12FD029DC9Q50504777-82751AFE-BC7F-4FB2-90FC-0981C01A29C1
P2860
Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pharmacogenetics in transplant ...... kinetics and pharmacodynamics?
@ast
Pharmacogenetics in transplant ...... kinetics and pharmacodynamics?
@en
type
label
Pharmacogenetics in transplant ...... kinetics and pharmacodynamics?
@ast
Pharmacogenetics in transplant ...... kinetics and pharmacodynamics?
@en
prefLabel
Pharmacogenetics in transplant ...... kinetics and pharmacodynamics?
@ast
Pharmacogenetics in transplant ...... kinetics and pharmacodynamics?
@en
P1476
Pharmacogenetics in transplant ...... kinetics and pharmacodynamics?
@en
P2093
Gilbert J Burckart
Xiaomei I Liu
P356
10.1097/01.FTD.0000194502.85763.BC
P577
2006-02-01T00:00:00Z